{"entity":{"type":"insider","cik":"0001647647","url":"/insider/0001647647","json_url":"/insider/0001647647.json","name":"Klencke Barbara","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2019-08-26","last":"2024-09-24","span_basis":"filed_date"},"name_variants":[{"name":"Klencke Barbara","source":"filing","n_filings":5,"first_seen":"2019-08-26","last_seen":"2024-09-24"}],"transactions":[{"id":2638870,"accession":"0000950170-24-109133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-109133","line_url":"/filing/0000950170-24-109133#line-1","is_derivative":false,"issuer_cik":"0001647647","issuer_name":"TScan Therapeutics, Inc.","issuer_ticker":"TCRX","issuer_name_source":null,"issuer_url":"/issuer/0001647647","owner_cik":"0001647647","owner_name":"Klencke Barbara","owner_display_name":"Klencke Barbara","owner_url":"/insider/0001647647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.29,"price_display":"5.29","price_state":"stated","total_value":26450.0,"total_display":"26,450.00","total_whole":"26,450","shares_owned_after":45000.0,"shares_owned_after_display":"45,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-23","filed_date":"2024-09-24","scope":"insider"},{"id":3216726,"accession":"0000950170-24-101166","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-101166","line_url":"/filing/0000950170-24-101166#line-2","is_derivative":false,"issuer_cik":"0001647647","issuer_name":"TScan Therapeutics, Inc.","issuer_ticker":"TCRX","issuer_name_source":null,"issuer_url":"/issuer/0001647647","owner_cik":"0001647647","owner_name":"Klencke Barbara","owner_display_name":"Klencke Barbara","owner_url":"/insider/0001647647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.53,"price_display":"5.53","price_state":"stated","total_value":27650.0,"total_display":"27,650.00","total_whole":"27,650","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-27","scope":"insider"},{"id":3216720,"accession":"0000950170-24-101166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-101166","line_url":"/filing/0000950170-24-101166#line-1","is_derivative":false,"issuer_cik":"0001647647","issuer_name":"TScan Therapeutics, Inc.","issuer_ticker":"TCRX","issuer_name_source":null,"issuer_url":"/issuer/0001647647","owner_cik":"0001647647","owner_name":"Klencke Barbara","owner_display_name":"Klencke Barbara","owner_url":"/insider/0001647647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.69,"price_display":"5.69","price_state":"stated","total_value":28450.0,"total_display":"28,450.00","total_whole":"28,450","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-27","scope":"insider"},{"id":8192944,"accession":"0000950170-23-071208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-071208","line_url":"/filing/0000950170-23-071208#line-1","is_derivative":false,"issuer_cik":"0001647647","issuer_name":"TScan Therapeutics, Inc.","issuer_ticker":"TCRX","issuer_name_source":null,"issuer_url":"/issuer/0001647647","owner_cik":"0001647647","owner_name":"Klencke Barbara","owner_display_name":"Klencke Barbara","owner_url":"/insider/0001647647","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.08,"price_display":"5.08","price_state":"stated","total_value":25400.0,"total_display":"25,400.00","total_whole":"25,400","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-14","filed_date":"2023-12-18","scope":"insider"},{"id":2737175,"accession":"0001209191-20-047352","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047352","line_url":"/filing/0001209191-20-047352","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001647647","owner_name":"Klencke Barbara","owner_display_name":"Klencke Barbara","owner_url":"/insider/0001647647","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9275.0,"shares_display":"9,275","price_per_share":12.2315,"price_display":"12.23","price_state":"stated","total_value":113447.1625,"total_display":"113,447.16","total_whole":"113,447","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-18","scope":"insider","n_lines":2},{"id":8395914,"accession":"0001209191-19-047421","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-047421","line_url":"/filing/0001209191-19-047421#line-3","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001647647","owner_name":"Klencke Barbara","owner_display_name":"Klencke Barbara","owner_url":"/insider/0001647647","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":108000.0,"shares_display":"108,000","price_per_share":0.4387,"price_display":"0.44","price_state":"stated","total_value":47379.6,"total_display":"47,379.60","total_whole":"47,380","shares_owned_after":162000.0,"shares_owned_after_display":"162,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-26","scope":"insider"},{"id":8395911,"accession":"0001209191-19-047421","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-047421","line_url":"/filing/0001209191-19-047421","is_derivative":false,"issuer_cik":"0001290149","issuer_name":"Sierra Oncology, Inc.","issuer_ticker":"SRRA","issuer_name_source":null,"issuer_url":"/issuer/0001290149","owner_cik":"0001647647","owner_name":"Klencke Barbara","owner_display_name":"Klencke Barbara","owner_url":"/insider/0001647647","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121000.0,"shares_display":"121,000","price_per_share":0.44015454545454546,"price_display":"0.44","price_state":"stated","total_value":53258.7,"total_display":"53,258.70","total_whole":"53,259","shares_owned_after":67000.0,"shares_owned_after_display":"67,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-08-22","filed_date":"2019-08-26","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001783328","name":"TScan Therapeutics, Inc.","url":"/issuer/0001783328","role":"Director","n_filings":3,"first_seen":"2023-12-18","last_seen":"2024-09-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001290149","name":"Sierra Oncology, Inc.","url":"/issuer/0001290149","role":"Officer (Chief Development Officer)","n_filings":2,"first_seen":"2019-08-26","last_seen":"2020-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001647647","retrieved_at":"2026-08-24T01:44:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}